ArticleMedComm2024

B cell pathway dual inhibition for systemic lupus erythematosus: a prospective single-arm cohort study of telitacicept.

Lanlan Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.